ArticleScientific reports2025
Alternative splicing in the RBMXL1 5'-UTR induces uORF-mediated translation control in activated B lymphocytes.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Functional analysis ofMolecular therapy. Nucleic acids · 2026Article
- An upstream open reading frame represses translation of the neuronal potassium channel KCNQ2.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- Tools and tactics for studying alternative splicing.Nature reviews. Genetics · 2026Review
- Targeted BDNF upregulation via upstream open reading frame disruption.Molecular therapy : the journal of the American Society of Gene Therapy · 2026Article
- Integrative analysis of YTHDC1 phosphoproteome unveils its phosphomodulatory network linked to splicing and tumorigenesis.Frontiers in bioinformatics · 2026Article
- Impact of the Diversity in the 5' UTR on Translation Regulation.Wiley interdisciplinary reviews. RNAReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The RNA binding motif X-linked (RBMX) gene plays multiple roles in gene transcription and alternative splicing regulation. Modifications to its expression have been associated with the development of various cancers. In addition to RBMX, there exist several RBMX-like genes (RBMXLs) that have been generated by retrotransposition of RBMX. Among these, RBMXL1 encodes a protein that is more than 95% identical to RBMX and may therefore fulfil similar functions. This study identified a specific variation in the alternative splicing of a small exon located in the 5'-untranslated region of the human RBMXL1 mRNA. This occurs following the infection of primary B lymphocytes by the Epstein-Barr virus (EBV) or their activation by a combination of CD40 Ligand and Interleukin 4. The inclusion of this small exon creates a small upstream open reading frame (uORF). Such uORFs have been described as having the capacity to regulate the translation of a downstream ORF. Our findings indicate that the RBMXL1 uORF is functional and that its presence results in the downregulation of the translation of the downstream primary ORF. Regulation of this alternative splicing may therefore play an important role in the fine-tuning of the global level of RBMX/RBMXL1 proteins in the cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.